8:00 a.m. – 8:30 a.m. Precision Medicine and Cancer: A View from the Intersection of Promise and Reality Alexander S. Parker, MS, PhD
8:30 a.m. – 9:00 a.m. Genetic Susceptibility to Breast Cancer: Beyond BRCA1 and 2 Freya Schnabel, MD
9:00 a.m. – 9:30 a.m. High Risk Breast Lesions: Morphology and Follow-up Management Shahla Masood, MD
9:30 a.m. – 10:00 a.m. Beyond Breast Density: Risk Assessment in the Breast Imaging Clinic Emily F. Conant, MD
10:00 a.m. – 10:30 a.m. BREAK and EXHIBITS
10:30 a.m. – 11:00 a.m. An Update on Breast Ultrasound Gary J. Whitman, MD
11:00 a.m. – 11:30 a.m. Abbreviated Breast MRI for Supplemental Screening Emily F. Conant, MD
11:30 a.m. – 12:00 p.m. Panel Discussion: Emily F. Conant, MD; Shahla Masood, MD; Alexander S. Parker, MS, PhD; Freya Schnabel, MD and Gary J. Whitman, MD
12:00 p.m. – 1:00 p.m. LUNCH AND EXHIBITS
Session II: Advances in Breast Cancer Therapy Moderator: Lisa Spiguel, MD
8:15 a.m. – 9:00 a.m. Keynote Lecture – Genomically-Informed Breast Cancer Therapy Debu Tripathy, MD
9:00 a.m. – 9:30 a.m. How to Select Genomic Assays Rationally? Jorge S. Reis-Filho, MD
9:30 a.m. – 10:00 a.m. Diversity in Breast Cancer Morphology and Biology: The Landscape of Triple Negative Breast Cancer Shahla Masood, MD
10:00 a.m. – 10:30 a.m. BREAK AND EXHIBITS
10:30 a.m. – 11:00 a.m. An Update on Immunotherapy Debu Tripathy, MD
11:00 a.m. – 11:30 a.m. An Update on Her2/neu Therapy Charles L. Shapiro, MD
11:30 a.m. – 12:00 p.m. Panel Discussion: Shahla Masood, MD; Jorge S Reis-Filho, MD; Charles L. Shapiro, MD and Debu Tripathy, MD
12:00 p.m. – 1:30 p.m. LUNCH AND EXHIBITS
12:30 p.m. – 1:00 p.m. LUNCH PRESENTATION – Liquid Biopsy: Is there a Role in Breast Cancer Management? Anthony M. Magliocco, MD (Not eligible for CME credit)
Session IV: Breast Cancer Therapy Moderator: Charles L. Shapiro, MD